Radial, a startup pursuing newer ways to treat mental health using brain stimulation and fast-acting medications, just raised $50 million in Series A and seed funding, Endpoints News learned exclusively. The company runs both software …
Lab-in-a-loop specialist Relation attracts Novartis alliance
UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.
#SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF bispecific in breast cancer
BioNTech and Bristol Myers Squibb on Tuesday shared positive mid-stage breast cancer results for their PD-L1xVEGF-A bispecific antibody, which they claim has the potential to be a treatment backbone across many different cancers. The drug …
#ASH25: Eli Lilly’s Jaypirca makes first-line case, but ceiling may be capped
ORLANDO, Fla. — Fresh off an approval of Jaypirca last week in second-line leukemia patients, Eli Lilly is now looking to move up to the first-line setting with impressive data presented Tuesday. The results, revealed at …
#ASH25: Novartis says its antibody ianalumab helps prolong control of rare blood disorder
Novartis said its latest experimental approach for a rare blood disorder prolonged patients’ disease control by 45% compared to a placebo arm. The Phase 3 results, which follow a topline readout in …
Eli Lilly will be ‘aggressive’ in spending GLP-1 money, top dealmaker Van Naarden says
ORLANDO, Fla. — Eli Lilly’s new chief dealmaker is planning to spend its GLP-1 cash in an “aggressive” but responsible manner. Last month, Lilly’s president of oncology Jacob Van Naarden was
FDA backs first AI tool for use in trials, targeting MASH
The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with MASH to help measure disease activity.
Mapping cognitive diversity in older adults through community-based digital screening via mobile devices: a cross-sectional latent class analysis
IntroductionEarly detection of objective cognitive impairment is essential to delay or prevent dementia; however, traditional in-person screening often faces practical barriers, including limited accessibility and substantial personnel demands. Web-based cognitive tools are promising for scalable screening. This study aimed to identify cognitive subgroups among community-dwelling older adults using latent class analysis (LCA) based on data […]
Gemini Enterprise No-Click Flaw Exposes Sensitive Data
Google has fixed a critical vulnerability that enabled attackers to add malicious instructions to common documents to exfiltrate sensitive corporate information.
Pfizer to pay $150M upfront for small molecule GLP-1 from Fosun subsidiary
On Nov. 19, Pfizer CFO Dave Denton said at the Jefferies Global Healthcare Conference that the large pharma was still looking for an oral small molecule for obesity and that it was …